Biogen Inc Drug Patent Portfolio

Biogen Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Biogen Inc News

Indian pharmaceutical company plans to offer Wegovy alternative at competitive prices, potentially up to a 60% discount.

18 Feb, 2026

An In-Depth Look at Biogen (BIIB): Transitioning from a Leader in MS to a Hub of Neuro-Innovation

06 Feb, 2026

Biogen Launches New Venture at JP Morgan 2026 | PharmExec

13 Jan, 2026

Lessons from Cancer Treatment Applied to Alzheimer's: A Multi-Target Drug Approach - OC Academy

12 Dec, 2025

See More